Full Text Journal Articles by
Author David Hardung

Advertisement

Find full text journal articles








Antithrombotic Treatment for Peripheral Arterial Occlusive Disease.

David Hardung, Andrea Behne, Mehmet Boral, Carsten Giesche, Ralf Langhoff,

<h4>Background</h4>Patients with peripheral arterial occlusive disease (PAOD) are at elevated risk for cardiovascular events and vascular events affecting the limbs. The goals of antithrombotic treatment are to keep vessels open after revascularization, to prevent cardiovascular events, and to lessen the frequency of peripheral ischemia and of amputation.<h4>Methods</h4>This review is based ... Read more >>

Dtsch Arztebl Int (Deutsches Arzteblatt international)
[2021, 118(Forthcoming):]

Cited: 0 times

View full text PDF listing >>



[Dual Pathway Inhibition in Atherosclerosis - Which Patients Benefit?]

David Hardung, Andrea Behne, Ralf Langhoff,

Dual antithrombotic therapy (DAT) with low-dose rivaroxaban in combination with acetylsalicylic acid (ASA) is available to patients with stable atherosclerotic disease as a new therapeutic option.The results of the COMPASS trial demonstrate a significant relative risk reduction of cardiovascular outcomes by 24 % with low-dose DAT in patients with stable peripheral ... Read more >>

Dtsch Med Wochenschr (Deutsche medizinische Wochenschrift (1946))
[2019, 144(20):1384-1389]

Cited: 0 times

View full text PDF listing >>



Advertisement

Real-world outcomes of endovascular treatment in a non-selected population with peripheral artery disease - prospective study with 2-year follow-up.

Karl-Ludwig Schulte, David Hardung, Christiane Tiefenbacher, Thomas Weiss, Ulrich Hoffmann, Klaus Amendt, Gunnar Tepe, Lothar Heuser, Andras Treszl, Hans-Joachim Lau, Thomas Pfannebecker, Karl Wegscheider,

<i>Background:</i> The study aimed to evaluate the outcomes of percutaneous transluminal angioplasty (PTA) in lower-extremity peripheral artery disease (PAD) patients. <i>Patients and methods:</i> A multi-centre, observational study was performed with 32 German and Austrian centres contributing data to the PTA registry. Data of 1,781 patients with lower-leg and pelvic PAD ... Read more >>

Vasa (VASA. Zeitschrift fur Gefasskrankheiten)
[2019, 48(5):433-441]

Cited: 1 time

View full text PDF listing >>



[Is an age-adjusted D-dimer cut-off value more accurate?--Age-adjusted D-dimer cut-off values clearly increase specificity].

David Hardung, Karl-Ludwig Schulte,

Dtsch Med Wochenschr (Deutsche medizinische Wochenschrift (1946))
[2013, 138(30):1500]

Cited: 0 times

View full text PDF listing >>



Post mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation.

Heyder Omran, Harald Schmidt, David Hardung, Christoph Hammerstingl, Giso von der Recke, Susanne Haas, Reinhard Büttner, Berndt Lüderitz,

Thromboemoblism is the most feared complication of atrial fibrillation. Percutaneous left atrial appendage occlusion is a new interventional procedure for reducing thromboembolic risk in patients with atrial fibrillation. The paper reports of a post mortem analysis of the device demonstrating that one year after implantation the atrial surface of the ... Read more >>

J Interv Card Electrophysiol (Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing)
[2005, 14(1):17-20]

Cited: 8 times

View full text PDF listing >>



Mechanical occlusion of the left atrial appendage.

Heyder Omran, David Hardung, Harald Schmidt, Christoph Hammerstingl, Berndt Lüderitz,

INTRODUCTION:Oral anticoagulation therapy reduces significantly the risk of thromboembolism in patients with atrial fibrillation. However, effective oral anticoagulation therapy is not feasible in all patients. The interventional occlusion of the left atrial appendage may reduce the risk of thromboembolism in the latter patients. The aim of this prospective study was ... Read more >>

J Cardiovasc Electrophysiol (Journal of cardiovascular electrophysiology)
[2003, 14(9 Suppl):S56-9]

Cited: 21 times

View full text PDF listing >>





Advertisement

Disclaimer
0.5581 s